文献速递冠心病外科

糖尿病患者CABG:SITA加桡动脉与BITA移植结局相似

Similar Outcomes in Diabetes Patients After Coronary Artery Bypass Grafting With Single Internal Thoracic Artery Plus Radial Artery Grafting and Bilateral Internal Thoracic Artery Grafting.
PubMed 文献 · Ann Thorac Surg · 2017-08-18

该研究纳入1994至2011年1325例接受初次孤立CABG的糖尿病患者,比较SITA+RA(±SV)与BITA(±SV)的院内结局和长期生存。倾向匹配282对后,两组院内死亡、深部胸骨伤口感染及1、5、10、14年生存率均相似。结论认为两种策略在糖尿病患者中结局相当,均可考虑。

要点

  • 糖尿病患者CABG中,SITA+RA与BITA的院内结局和长期生存相似。
  • 倾向匹配后两组院内死亡均为0.35%,深部胸骨伤口感染均为1.4%。
  • 匹配后1、5、10、14年生存率两组差异无统计学意义。

核心结论

  • 糖尿病患者接受SITA+RA(±SV)或BITA(±SV)CABG,院内结局和长期生存相似。

研究设计与样本

  • 回顾性队列研究,纳入1994年1月至2011年1月1325例糖尿病患者,均行初次孤立CABG。
  • SITA+RA(±SV)组965例,BITA(±SV)组360例,所有患者均用内乳动脉移植左前降支。
  • 中位随访7.4年,总随访9162患者年,倾向评分匹配282对。

主要发现

  • 未调整院内死亡率:SITA+RA(±SV)组0.52%,BITA(±SV)组0.28%。
  • 未调整深部胸骨伤口感染率:SITA+RA(±SV)组3.2%,BITA(±SV)组1.7%。
  • 未调整1、5、10、14年生存率:SITA+RA(±SV)组97%、88%、68%、51%,BITA(±SV)组97%、95%、80%、66%。
  • 倾向匹配后院内死亡率两组均为0.35%,深部胸骨伤口感染率均为1.4%(p>0.9)。
  • 匹配后1、5、10、14年生存率:SITA+RA(±SV)组97%、90%、70%、58%,BITA(±SV)组97%、93%、79%、64%(早期p=0.8,晚期p=0.2)。

临床怎么用

  • 糖尿病患者CABG时,SITA+RA(±SV)和BITA(±SV)均可考虑,两者院内结局和长期生存相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to determine in patients with diabetes mellitus whether single internal thoracic artery (SITA) plus radial artery (RA) grafting yields outcomes similar to those of bilateral internal thoracic artery (BITA) grafting. METHODS: From January 1994 to January 2011, 1,325 diabetic patients underwent primary isolated coronary artery bypass graft surgery with either (1) SITA plus RA with or without saphenous vein (SV) grafts (n = 965) or (2) BITA with or without SV grafts (n = 360); an internal thoracic artery was used in all patients to graft the left anterior descending coronary artery. Endpoints were in-hospital outcomes and time-related mortality. Median follow-up was 7.4 years, with a total follow-up of 9,162 patient-years. Propensity score matching was performed to identify 282 well-matched pairs for adjusted comparisons. RESULTS: Unadjusted in-hospital mortality was 0.52% for SITA plus RA with or without SV grafts and 0.28% for BITA with or without SV grafts, and prevalence of deep sternal wound infection was 3.2% and 1.7%, respectively. Unadjusted survival at 1, 5, 10, and 14 years was 97%, 88%, 68%, and 51% for SITA plus RA with or without SV grafts, and 97%, 95%, 80%, and 66% for BITA with or without SV grafts, respectively. Among propensity-matched patients, in-hospital mortality (0.35% versus 0.35%) and prevalence of deep sternal wound infection (1.4% versus 1.4%) were similar (p > 0.9) in the two groups, as was 1-, 5-, 10-, and 14-year survival: 97%, 90%, 70%, and 58% for SITA plus RA with or without SV grafting versus 97%, 93%, 79%, and 64% for BITA with or without SV grafting, respectively (early p = 0.8, late p = 0.2). CONCLUSIONS: For diabetic patients, SITA plus RA with or without SV grafting and BITA with or without SV grafting yield similar in-hospital outcomes and long-term survival after coronary artery bypass graft surgery. Therefore, both SITA plus RA and BITA plus SV grafting should be considered for these patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Raza S, Blackstone EH, Houghtaling PL, et al. Similar Outcomes in Diabetes Patients After Coronary Artery Bypass Grafting With Single Internal Thoracic Artery Plus Radial Artery Grafting and Bilateral Internal Thoracic Artery Grafting. Ann Thorac Surg. 2017. PMID: 28826992. doi:10.1016/j.athoracsur.2017.05.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。